The effect of low preoperative platelet count on adverse outcomes following lumbar microdiscectomy

Stephan Aynaszyan1, Idorenyin F Udoeyo2, Edward M DelSole1,2

  • 1Geisinger Commonwealth School of Medicine, 525 Pine St., Scranton, PA, 18510, USA.

Abstract

Insights

Low preoperative platelet counts (thrombocytopenia) do not independently predict complications after lumbar microdiscectomy. However, comorbidities like diabetes and smoking increase risks for adverse events in these patients.

Area of Science:

  • Neurosurgery
  • Hematology
  • Surgical Outcomes Research

Background:

  • Low preoperative platelet count (thrombocytopenia) is linked to surgical complications.
  • Previous research has not specifically examined thrombocytopenia's impact on lumbar microdiscectomy (MLD) outcomes.
  • This study investigates abnormal coagulation profiles in MLD patients.

Purpose of the Study:

  • To determine if low preoperative platelet count independently predicts adverse postoperative outcomes after MLD.
  • To identify factors associated with increased risk of return to the operating room or surgical site infection post-MLD.

Main Methods:

  • Retrospective analysis of 64,747 patients undergoing MLD (CPT code 63030) from 2010-2019.
  • Patients categorized into four platelet count groups for analysis.
  • Multivariate and propensity matched analyses used to assess predictors of adverse events (return to OR, surgical site infection).

Main Results:

  • Low preoperative platelet count was not a significant independent predictor of return to the operating room or surgical site infection.
  • Diabetes, smoking history, and emergency case status were associated with higher likelihood of adverse events.
  • No significant differences in adverse outcomes were found based on preoperative platelet levels.

Conclusions:

  • Thrombocytopenia does not appear to independently predict return to the operating room or postoperative infection following MLD.
  • Preoperative management should focus on comorbidity burden to mitigate risks in MLD patients.
  • Adverse outcomes in thrombocytopenic patients undergoing MLD are influenced by other factors.